National Clinical Trials Network
GPTKB entity
Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Research_Institute
|
| gptkbp:aimsTo |
enhance collaboration among researchers
accelerate drug development improve patient access to clinical trials reduce disparities in cancer care streamline trial processes |
| gptkbp:collaboratesWith |
academic institutions
pharmaceutical companies community hospitals |
| gptkbp:established |
gptkb:National_Cancer_Institute
|
| gptkbp:facilitates |
patient enrollment in trials
|
| gptkbp:focusesOn |
cancer research
|
| gptkbp:hasPart |
gptkb:Cancer_Trials_Support_Unit
NCTN_Coordinating_Center NCTN_Group_Operations |
| gptkbp:hasPrograms |
NCTN_Group
NCTN_Operations_Center NCTN_Statistics_and_Data_Center |
| https://www.w3.org/2000/01/rdf-schema#label |
National Clinical Trials Network
|
| gptkbp:includes |
multiple cancer research organizations
|
| gptkbp:isActiveIn |
2014
|
| gptkbp:isFundedBy |
gptkb:National_Institutes_of_Health
|
| gptkbp:isInvolvedIn |
regulatory compliance
community outreach programs safety monitoring adverse event reporting treatment protocols precision medicine research collaborations data sharing initiatives phase I trials phase II trials phase III trials survivorship research patient-centered outcomes research health economics research quality of life studies phase IV trials multinational trials biomarker_research |
| gptkbp:isSupportedBy |
grants
government funding private donations |
| gptkbp:operatesIn |
gptkb:United_States
|
| gptkbp:provides |
data collection and analysis
patient education materials resources for trial design clinical trial infrastructure guidelines for trial conduct training for clinical trial staff |
| gptkbp:supports |
innovative cancer treatments
|